EU Drug Market: New psychoactive substances — References

Advisory Committee on the Misuse of Drugs (2022), ‘ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazolone opioids’, https://www.gov.uk/government/publications/acmd-advice-on-2-benzyl-benzimidazole-and-piperidine-benzimidazolone-opioids/acmd-advice-on-2-benzyl-benzimidazole-and-piperidine-benzimidazolone-opioids-accessible-version.

Arrling, A. and Ziegerer, J. ‘Europas lustgasbaroner: Våra produkter används inte till att berusa sig’,  Helsingborgs Dagblad, https://www.hd.se/2023-09-30/europas-lustgasbaroner-vara-produkter-anvands-inte-till-att-berusa-sig.

Australian Federal Police (2023), 'NT man charged over potent opioid mail import, prompts warning', https://www.afp.gov.au/news-centre/media-release/nt-man-charged-over-po….

Blakey, K., Thompson, A., Matheson, A. and Griffiths, A. (2022), ‘What’s in fake “Xanax”?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets’’, Drug Testing and Analysis 14(3), pp. 525-530, doi:10.1002/dta.3119.

Bowles, J. M., McDonald, K., Maghsoudi, N., Thompson, H., Stefan, C., Beriault, D. R., Delaney, S., Wong, E. and Werb, D. (2021), ‘Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications’, Harm Reduction Journal 18(1), doi:10.1186/s12954-021-00546-9.

CFSRE (2022), 'Bromazolam prevalence surging ccross the United States driven in part by increasing detections alongside fentanyl', 15 June, https://www.cfsre.org/nps-discovery/public-alerts/bromazolam-prevalence-surging-across-the-united-states-driven-in-part-by-increasing-detections-alongside-fentanyl.

CND (2020a), ‘Decision 63/13. Inclusion of etizolam in Schedule IV of the Convention on Psychotropic Substances of 1971’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2020/Decision_63_13.pdf.

CND (2020b), ‘Decision 63/12. Inclusion of flualprazolam in Schedule IV of the Convention on Psychotropic Substances of 1971’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2020/Decision_63_12.pdf.

CND (2021a), ‘Decision 64/1. Inclusion of isotonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2021/decision_64_1.pdf.

CND (2021b), ‘Decision 64/6. Inclusion of clonazolam in Schedule IV of the Convention on Psychotropic Substances of 1971’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2021/decision_64_6.pdf.

CND (2021c), ‘Decision 64/8. Inclusion of flubromazolam in Schedule IV of the Convention on Psychotropic Substances of 1971’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2021/decision_64_8.pdf.

CND (2022), ‘Decision 65/2. Inclusion of metonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2022/Dec_65_1_to_4.pdf.

CND (2023), ‘Decision 66/4. Inclusion of protonitazene in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol’, https://www.unodc.org/documents/commissions/CND/Drug_Resolutions/2020-2029/2023/Dec_66_1_2305857E.pdf.

Collins, M., Doddridge, A. and Salouros, H. (2016), ‘Cathinones: Isotopic profiling as an aid to linking seizures’, Drug Testing and Analysis 8(9), pp. 903-909, doi:10.1002/dta.1886.

Daly, M. (2022), 'Prisoners are getting high on underwear soaked in drugs', Vice, https://www.vice.com/en/article/pkpx9b/prisoners-are-getting-high-on-un….

De Baerdemaeker, K. S. C., Dines, A. M., Hudson, S., Sund, L. J., Waters, M. L., Hunter, L. J., Blundell, M. S., Archer, J. R. H., et al. (2023), ‘Isotonitazene, a novel psychoactive substance opioid, detected in two cases following a local surge in opioid overdoses’, QJM 116(2), pp. 115-119, doi:10.1093/qjmed/hcac039.

Di Nicola, G. (2022), ‘Cocaína adulterada: el carfentanilo, un opioide usado para sedar elefantes, es la sustancia letal’,  La Nacion, https://www.lanacion.com.ar/seguridad/cocaina-adulterada-se-conocio-la-sustanciautilizada-para-cortar-la-droga-letal-nid10022022/.

Drug Enforcement Administration (DEA) (2023), NFLIS-Drug 2022 Annual Report, https://www.nflis.deadiversion.usdoj.gov/nflisdata/docs/2022NFLIS-DrugAnnualReport.pdf.

Drug Information and Alerts Aotearoa New Zealand (2022), ‘Highly potent opioid found in fake oxycodone tablets’,  Highalert.

El Balkhi, S., Monchaud, C., Herault, F., Géniaux, H. and Saint-Marcoux, F. (2020), ‘Designer benzodiazepines’ pharmacological effects and potencies: how to find the information’, Journal of Psychopharmacology 34(9), pp. 1021-1029, doi:10.1177/0269881119901096.

EMCDDA (2008), GHB and its precursor GBL: an emerging trend case study, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2017), 'Production of NPS in the EU: an emerging threat', Briefing note, unpublished.

EMCDDA and Europol (2018), EMCDDA Synthetic opioids: spotlight on fentanils Joint Europol-EMCDDA Threat Assessment, Document Reference EDOC# 937936.

EMCDDA and Europol (2019), EU drug markets report 2019, Publications Office of the European Union, Luxembourg.

EMCDDA (2020), Report on the risk assessment of N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended), Publications Office of the European Union, Luxembourg.

EMCDDA (2021a), Synthetic cannabinoids in Europe — a review, Publications Office of the European Union, Luxembourg.

EMCDDA (2021b), New benzodiazepines in Europe — a review, Publications Office of the European Union, Luxembourg.

EMCDDA (2022a), New psychoactive substances: 25 years of early warning and response in Europe: an update from the EU Early Warning System, Rapid Communications, Publications Office of the European Union, Luxembourg.

EMCDDA (2022b), Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended), Risk Assessments, Publications Office of the European Union, Luxembourg.

EMCDDA (2022c), Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended), Risk Assessments, Publications Office of the European Union, Luxembourg.

EMCDDA (2022d), Recreational use of nitrous oxide: a growing concern for Europe, Rapid Communications, Publications Office of the European Union, Luxembourg.

EMCDDA (2023), Hexahydrocannabinol (HHC) and related substances, Technical report, Publications Office of the European Union, Luxembourg.

ESPAD Group (2020), ESPAD Report 2019: Results from the European School Survey Project on Alcohol and Other Drug, Publications Office of the European Union, Luxembourg.

Essink, S., Nugteren-van Lonkhuyzen, J. J., van Riel, A. J. H. P., Dekker, D. and Hondebrink, L. (2022), 'Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020', Drug and alcohol dependence 231, 109244, doi:10.1016/j.drugalcdep.2021.109244.

Europol (2019), 'EU Manual on illicit synthetic drugs/NPS production', Europol, The Hague (unpublished).

Fan, X., Zhang, J., Fu, X., Zhou, B., Xu, Z., Huang, H., Han, S. and Li, X. (2022), ‘Analysis of synthetic cannabinoids in wastewater of major cities in China’, The Science of the Total Environment 827, 154267, doi:10.1016/j.scitotenv.2022.154267.

Ford, L. T. and Berg, J. D. (2018), 'Analytical evidence to show letters impregnated with novel psychoactive substances are a means of getting drugs to inmates within the UK prison service', Annals of clinical biochemistry 55(6), pp.673-678, doi:10.1177/0004563218767462.

Forensic Science Ireland (2023), ‘Forensic Science Ireland annual report 2022’, https://forensicscience.ie/documents/FSI%202022%20Annual%20Report.pdf.

Friedman, J., Montero, F., Bourgois, P., Wahbi, R., Dye, D., Goodman-Meza, D. and Shover, C. (2022), ‘Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis’, Drug and Alcohol Dependence 233, 109380, doi:10.1016/j.drugalcdep.2022.109380.

Hussien, R., Ahmed, S., Awad, H., El-Setouhy, M., El-Shinawi, M. and Hirshon, J. M. (2022), ‘Identification of “Voodoo”: an emerging substance of abuse in Egypt’, International Journal of Environmental Analytical Chemistry 102(1), pp. 104-116, doi:10.1080/03067319.2020.1715384.

Kriikku, P., Rasanen, I., Ojanperä, I., Thelander, G., Kronstrand, R. and Vikingsson, S. (2020), ‘Femoral blood concentrations of flualprazolam in 33 postmortem cases’, Forensic Science International 307, 110101, doi:10.1016/j.forsciint.2019.110101.

Krotulski, A. J., Papsun, D. M., Walton, S. E., Fogarty, M. F. and Logan, B. K. (2021), NPS discovery: year in review 2021, Center for Forensic Science Research and Education (CFSRE), https://www.cfsre.org/images/trendreports/yir-2021/YearInReview-2021.pdf.

Laing, M. K., Ti, L., Marmel, A., Tobias, S., Shapiro, A. M., Laing, R., Lysyshyn, M. and Socías, M. E. (2021), ‘An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and confirmatory methods’, The International Journal on Drug Policy 93, 103169, doi:10.1016/j.drugpo.2021.103169.

Latvian Ministry of Interior (2020), 'Dissolved laboratory in which dangerous narcotic substance has been removed', 15 July, https://www.iem.gov.lv/en/article/dissolved-laboratory-which-dangerous-narcotic-substance-has-been-removed.

Latvian Police (2023), 'Aizturētas ar fentanila nelikumīgu ražošanu un realizēšanu saistītas personas', 31 May, https://www.vp.gov.lv/lv/jaunums/aizturetas-ar-fentanila-nelikumigu-razosanu-un-realizesanu-saistitas-personas.

Liu, C.-M., Hua, Z.-D., Jia, W. and Li, T. (2022), ‘Identification of AD-18, 5F-MDA-19, and pentyl MDA-19 in seized materials after the class-wide ban of synthetic cannabinoids in China’, Drug Testing and Analysis, doi:10.1002/dta.3185.

McAuley, A., Matheson, C. and Robertson, J. R. (2022), ‘From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic’, The International Journal on Drug Policy 100, 103512, doi:10.1016/j.drugpo.2021.103512.

Metropolitan Police (2023), '11 charged as detectives seize UK’s largest ever haul of synthetic opioids', 23 November, https://news.met.police.uk/news/11-charged-as-detectives-seize-uks-largest-ever-haul-of-synthetic-opioids-475759.

Ministerio de Salud (2022), 'Recomendaciones del Ministerio de Salud ante los casos de intoxicación en la Provincia de Buenos Aires tras el consumo de cocaína', 2 February, https://www.argentina.gob.ar/noticias/recomendaciones-ante-casos-de-intoxicacion-en-pcia-de-buenos-aires-tras-el-consumo-de.

Moosmann, B., Angerer, V. and Auwärter, V. (2015), ‘Inhomogeneities in herbal mixtures: a serious risk for consumers’, Forensic Toxicology 33, pp. 54-60, doi:10.1007/s11419-014-0247-4.

National Police of the Netherlands (2022), National strategic assessment of drug-related serious and organised crime in the Netherlands 2021, National Police of the Netherlands, Zoetermeer.

Pardo, B. (2022), ‘Insights into mixing fentanyl and benzodiazepines from Canadian drug seizures’, JAMA Psychiatry 79(1), pp. 81-83, doi:10.1001/jamapsychiatry.2021.3292.

Reyes, J. C., Negrón, J. L., Colón, H. M., Padilla, A. M., Millán, M. Y., Matos, T. D., and Robles, R. R. (2012), 'The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico', Journal of Urban Health: Bulletin of the New York Academy of Medicine, 89(3), pp. 519-526, doi:10.1007/s11524-011-9662-6

Rice, K., Hikin, L., Lawson, A., Smith, P. R. and Morley, S. (2021), ‘Quantification of flualprazolam in blood by LC-MS-MS: a case series of nine deaths’, Journal of Analytical Toxicology 45(4), pp. 410-416, doi:10.1093/jat/bkaa098.

Rodrigues, T. B., Souza, M. P., Melo Barbosa, L., Carvalho Ponce, J., Neves Jnr., L. F., Yonamine, M. and Costa, J. L. (2022), ‘Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons’, Forensic Toxicology 40, pp. 119-124, doi:10.1007/s11419-021-00586-7.

Shao, X. T., Yu, H., Lin, J. G., Kong, X. P., Wang, Z. and Wang, D. G. (2021), ‘Presence of the ketamine analog of 2-fluorodeschloroketamine residues in wastewater’, Drug Testing and Analysis 13(9), pp. 1650-1657, doi:10.1002/dta.3098.

Spanish Police (2023), ‘Desmantelado en Barcelona un laboratorio de fabricación de nuevas sustancias psicoactivas NSP’, https://www.policia.es/_es/comunicacion_prensa_detalle.php?ID=15913.

Sternbach L. H. (1978), 'The benzodiazepine story. Progress in drug research', Fort-schritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 22, pp. 229-266, doi:10.1007/978-3-0348-7102-05.

Syrjanen, R., Greene, S. L. and Weber, C. (2023), ‘Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022’, International Journal of Drug Policy, doi:10.1016/j.drugpo.2023.104245.

ter Laak, T. L. and Emke, E. (2023), ‘Environmental impact of synthetic drug production: analysis of groundwater samples for contaminants derived from illicit synthetic drug production waste’, EMCDDA commissioned paper, EMCDDA, Lisbon.

Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., Morais, J. and Sedefov, R. (2021), ‘DARK classics in chemical neuroscience: etonitazene and related benzimidazoles’, ACS Chemical Neuroscience 12(7), pp. 1072-1092, doi:10.1021/acschemneuro.1c00037.

UNODC (2021), At the crossroads of licit and illicit. Tramadol and other pharmaceutical opioids trafficking in West Africa, UNODC, Vienna, https://www.unodc.org/documents/nigeria/Tramadol_Trafficking_in_West_Africa.pdf.

UNODC (2022), ‘World drug report 2022: Statistical Annex - 9. Illicit manufacturing of drugs’, UNODC, https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html.

UNODC (2023), 'World drug report 2023', UNODC, https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html.

Von Schläpfer, M., Bissig, C. and Bogdal, C. (2020), ‘Synthetische Cannabimimetika auf Industriehanfblüten. Ein gefährliches Aufeinandertreffen zweier bekannter Phänomene’, Kriminalistik 07, pp. 433-435, https://www.kriminalistik.de/ausgabe_07_2020.htm#Artikel12.

Wojciech, W. (2022), 'Production of cathinone derivatives in Poland', communication to the EMCDDA from criminal office of the Police headquarters, unpublished.

Wong, S. C., Curtis, J. A. and Wingert, W. E. (2008), ‘Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner’s Office’, Journal of Forensic Sciences 53(2), pp. 495-498, doi:10.1111/j.1556-4029.2007.00648.x.

Wrzesień, W., Stanaszek, R., Zuba, D. and Byrska, B. (2018), ‘Clandestine laboratory producing mephedrone (4-mmc) and clephedrone (4-cmc): substance identification and hazard analysis’, Problems of Forensic Sciences 115(CXV), pp. 287-309, https://arch.ies.gov.pl/index.php/2018?view=article&id=60:clandestine-laboratory-producing-mephedrone-4-mmc-and-clephedrone-4-cmc-substance-identification-and-hazard-analysis&catid=10:artykuly.

Zagorski, C. M., Myslinski, J. M. and Hill, L. G. (2020), ‘Isotonitazene as a contaminant of concern in the illegal opioid supply: A practical synthesis and cost perspective’, International Journal of Drug Policy 22, 102939, doi:10.1016/j.drugpo.2020.102939.